These results, together with a earlier report exhibiting that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like habits in mice,two support the concept of focusing on ACKR3 as a unique technique to modulate the opioid process, which could open new therapeutic avenues for opioid-similar Conditions. Take note: Final results may https://paulp044bfw5.actoblog.com/profile